黄芪多糖对咪喹莫特诱导小鼠银屑病样皮炎的干预作用及其机制*

doi:10.12047/j.cjap.6214.2022.022

摘要/Abstract

摘要： 目的: 探讨黄芪多糖对咪喹莫特诱导的小鼠银屑病样皮炎的干预作用及其机制。方法: 40只健康雌性C57BL/6小鼠随机分为空白对照组、模型组、黄芪多糖高剂量组(200 mg/kg)、中剂量组(100 mg/kg)和低剂量组(50 mg/kg),共5组,每组8只,利用5%咪喹莫特乳膏涂抹小鼠背部制备银屑病样皮炎模型,监测各组小鼠PASI评分,并采用ELISA测定小鼠炎症因子分泌的变化,通过流式细胞术检测皮炎中巨噬细胞的浸润程度。结果: 与空白对照组比较,模型组小鼠PASI评分明显增加(P＜0.05),血清TNF-α、IL-1β和IL-6水平明显升高(P＜0.05),皮肤组织中浸润的巨噬细胞明显增加(P＜0.05);与模型组比较,黄芪多糖高、中剂量组小鼠PASI评分明显明显减少(P＜0.05),小鼠血清TNF-α、IL-1β和IL-6水平明显下调(P＜0.05);黄芪多糖高剂量组小鼠皮肤组织中浸润的巨噬细胞明显减少(P＜0.05)。结论: 黄芪多糖通过抑制皮肤组织中巨噬细胞浸润,降低血清中TNF-α、IL-1β和IL-6的分泌,来改善小鼠银屑病样皮炎。

关键词: 黄芪多糖, 咪喹莫特, 银屑病样皮炎, 巨噬细胞浸润, 小鼠

Abstract: Objective: To investigate the effects and mechanisms of Astragalus polysaccharide on improving imiquimod-induced psoriasiform dermatitis in mice. Methods: Forty healthy female C57BL/6 mice were randomly divided into 5 groups, including blank control group, model group, astragalus polysaccharide high-dose group (200 mg/kg), medium-dose group (100 mg/kg) and low-dose group (50 mg/kg), with 8 mice in each group. The mice in model group and astragalus polysaccharide treatment group were treated with 5% imiquimod cream on the back to induce psoriasiform dermatitis. PASI score was monitored, and the secretion of inflammatory factors was determined by ELISA. The secretion of inflammatory factors was closely related to the infiltration of macrophages. The infiltration of macrophages in skin was detected by flow cytometry to further explore the effect of different concentrations of APS on psoriasis. Results: Compared with control group, the PASI score and the serum levels of TNF-α, IL-1β and IL-6 were increased significantly (P＜0.05), and the infiltration of macrophages in skin tissue was increased significantly in model group (P＜0.05). Compared with model group, the PASI score was decreased significantly (P＜0.05), and the serum levels of TNF-α, IL-1β and IL-6 were down-regulated significantly in astragalus polysaccharide high-dose and medium-dose groups (P＜0.05). The infiltrating macrophages in skin tissue were decreased significantly in Astragalus polysaccharide high-dose group (P＜0.05). Conclusion: Astragalus polysaccharide improve psoriasiform dermatitis in mice by inhibiting the infiltration of macrophages in skin tissue and decreasing the secretion of TNF-α, IL-1β and IL-6 in serum.

Key words: astragalus polysaccharide, imiquimod, psoriasiform dermatitis, macrophage infiltration, mice

中图分类号:

陈若玺, 郑胜, 郭春燕, 张强. 黄芪多糖对咪喹莫特诱导小鼠银屑病样皮炎的干预作用及其机制^*[J]. 中国应用生理学杂志, 2022, 38(2): 154-159.

CHEN Ruo-xi, ZHENG Sheng, GUO Chun-yan, ZHANG Qiang. Effects of Astragalus polysaccharide on imiquimod-induced psoriasiform dermatitis in mice and its mechanisms[J]. CJAP, 2022, 38(2): 154-159.

参考文献

[1] Li Q, Liu W, Gao S, et al. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist [J]. BMC Immunol, 2021, 22(1): 11.
[2] He X, Zhu B, Xie W, et al. Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel [J]. Bioact Mater, 2021, 6(2): 299-311.
[3] Kiss B, Szanto M, Hegedus C, et al. Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis [J]. Exp Dermatol, 2020, 29(1): 79-85.
[4] Guo J, Liu Y, Guo X, et al. Depressive-like behaviors in mice with Imiquimod-induced psoriasis [J]. Int Immunopharmacol, 2020, 89(Pt B): 107057.
[5] Choi CW, Kim BR, Yang S, et al. Regulatory T cells suppress skin inflammation in the imiquimod-induced psoriasis-like mouse model [J]. J Dermatol Sci, 2020, 98(3): 199-202.
[6] Singh TP, Zhang HH, Hwang ST, et al. IL-23- and imiquimod-induced models of experimental psoriasis in mice[J]. Curr Protoc Immunol, 2019, 125(1): e71.
[7] Sun J, Wei S, Zhang Y, et al. Protective effects of astragalus polysaccharide on sepsis-induced acute kidney injury[J]. Anal Cell Pathol(Amst), 2021, 2021: 7178253.
[8] Li C, Pan XY, Ma M, et al. Astragalus polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages[J]. Pharm Biol, 2021, 59(1): 1533-1539.
[9] Zhang G, Fang H, Li Y, et al. Neuroprotective effect of astragalus polysacharin on streptozotocin(STZ)-induced diabetic rats[J]. Med Sci Monit, 2019, 25: 135-141.
[10] Shao F, Tan T, Tan Y, et al. Andrographolide alleviates imiquimod-induced psoriasis in mice via inducing autophagic proteolysis of MyD88[J]. Biochem Pharmacol, 2016, 115: 94-103.
[11] Goenaga-Vazquez Y, Lauck KC, Hebert A. A Therapeutic challenges in managing pediatric psoriasis[J]. Int J Womens Dermatol, 2021, 7(3): 314-318.
[12] Jadali Z. Unfulfilled inflammatory resolution: A key factor in the pathogenesis of psoriasis[J]. Iran J Allergy Asthma Immunol, 2020, 19(4): 337-347.
[13] Zeng J, Chen X, Lei K, et al. Mannan-binding lectin promotes keratinocyte to produce CXCL1 and enhances neutrophil infiltration at the early stages of psoriasis[J]. Exp Dermatol, 2019, 28(9): 1017-1024.
[14] Schuster C, Huard A, Sirait-Fischer E, et al. S1PR4-dependent CCL2 production promotes macrophage recruitment in a murine psoriasis model [J]. Eur J Immunol, 2020, 50(6): 839-845.
[15] Hou Y, Zhu L, Tian H, et al. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis [J]. Protein Cell, 2018, 9(12): 1027-1038.
[16] Li L, Zhang HY, Zhong XQ, et al. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization [J]. Life Sci, 2020, 243: 117231.
[17] Papp KA, Gooderham M, Jenkins R, et al. Granulocyte-macrophage colony-stimulating factor(GM-CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti-GM-CSF monoclonal antibody [J]. Br J Dermatol, 2019, 180(6): 1352-1360.
[18] Leite Dantas R, Masemann D, Schied T, et al. Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes [J]. J Pathol, 2016, 240(3): 366-377.
[19] Ropke M, Bulai Livideanu C, Kaldate R, et al. Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study [J]. Br J Dermatol, 2018, 178(1): e33-e34.
[20] Deng G, Chen W, Wang P, et al. Inhibition of NLRP3 inflammasome-mediated pyroptosis in macrophage by cycloastragenol contributes to amelioration of imiquimod-induced psoriasis-like skin inflammation in mice [J]. Int Immunopharmacol, 2019, 74: 105682.
[21] Liu T, Zhang M, Niu H, et al. Astragalus polysaccharide from astragalus melittin ameliorates inflammation via suppressing the activation of TLR-4/NF-kappaB p65 signal pathway and protects mice from CVB3-induced virus myocarditis [J]. Int J Biol Macromol, 2019, 126: 179-186.
[22] Yue D, You Y, Zhang X, et al. CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by Vgamma4(+) gammadelta T cells [J]. J Autoimmun, 2019, 101: 70-85.

黄芪多糖对咪喹莫特诱导小鼠银屑病样皮炎的干预作用及其机制^*

Effects of Astragalus polysaccharide on imiquimod-induced psoriasiform dermatitis in mice and its mechanisms

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	武南南, 封芮芮, 张宇, 李光, 曹济民, 殷丽天. Synaptotagmin 1基因敲除对小鼠行为的影响^*[J]. 中国应用生理学杂志, 2022, 38(2): 97-101.
[2]	陈均, 高扬, 苏香楠, 于亮. 6周有氧运动对高脂膳食的ApoE敲除小鼠骨骼肌钙调控的影响^*[J]. 中国应用生理学杂志, 2022, 38(2): 137-142.
[3]	王海涛, 杨雯茜, 刘玉倩. 有氧运动对高脂膳食小鼠心肌损伤中Nrf2/GPX4/Ferroptosis通路的作用^*[J]. 中国应用生理学杂志, 2022, 38(2): 143-148.
[4]	李永荣, 谢海彬, 李红, 孙杰. 地塞米松联合缬沙坦对慢性阻塞性肺疾病小鼠保护作用及机制探讨^*[J]. 中国应用生理学杂志, 2022, 38(2): 149-153.
[5]	王煜, 王自立, 王志旺, 李喜香, 李济阳. 润肠通便合剂对便秘模型小鼠结肠MUC2、AQP3的影响^*[J]. 中国应用生理学杂志, 2022, 38(2): 159-162.
[6]	郝凯敏, 刘镇, 王浩玉, 祁文秀. PTK2B与Aβ、Tau和LRP-1在APP/PS1小鼠海马组织和血液中的表达随月龄变化的分析^*[J]. 中国应用生理学杂志, 2022, 38(1): 17-24.
[7]	覃超群, 黄斌, 阳芳, 王昌明, 肖影, 莫艳菊, 廖艺, 高枫. GSK3β/eEF2K信号通路对小鼠肺纤维化过程的影响^*[J]. 中国应用生理学杂志, 2022, 38(1): 32-36.
[8]	马媛, 荀敬, 王波涛, 李棣华, 张琦, 王震宇, 吴瑜. 旋覆代赭汤对食管癌细胞干性的影响^*[J]. 中国应用生理学杂志, 2022, 38(1): 62-67.
[9]	白林林, 王志华, 宁学聪, 巩翠珂, 李爱敏, 段玉玲, 焦雨佼. IL-17A对慢性阻塞性肺疾病的干预作用及其机制^*[J]. 中国应用生理学杂志, 2021, 37(6): 584-588.
[10]	薛峰, 王辉, 许思多, 刘首挺, 龚永生, 范小芳. 左旋卡尼汀对脂多糖诱导小鼠肺微血管内皮细胞自噬和凋亡的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 589-593.
[11]	李莉, 黄涵柽. 莱菔子乙醇提取物对ApoE^-/-小鼠血脂血糖及肝脂肪变性的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 622-627.
[12]	胡佳楠, 姜辉, 李美琦, 朱俐, 骆倩倩. 模拟高原低氧环境对小鼠脾脏铁代谢的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 628-631.
[13]	李萍, 梁琳琅, 王宇, 侯达, 杨昕, 杨博. 二甲双胍和西格列汀对胰岛素抵抗糖尿病前期KKAy小鼠胰岛β细胞功能的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 644-649.
[14]	袁前发, 何珏, 徐志忠, 林多朵, 朱敬敬, 温春燕, 段海珍, 王文强. 重复经颅磁刺激联合低剂量氟西汀对CUMS抑郁小鼠的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 650-653.
[15]	谢文杰, 周刚, 李鹏飞, 杨帆, 安静芳, 李航. 游泳训练对小鼠心肌PKCδ/P66shc蛋白表达的影响^*[J]. 中国应用生理学杂志, 2021, 37(6): 688-693.